Many lines of evidence have indicated that AFP inhibits the immune response in patients with cancers (Um et al., 2004; Meng et al., 2016; Suryatenggara et al., 2017; Wang and Wang, 2018; Zheng et al., 2020). Here, AFP is linked to cancer.